Trastuzumab Plus Docetaxel in Treating Women With Recurrent or Metastatic Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ingrid Mayer, MD
Vanderbilt-Ingram Cancer Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Providence Hospital
Mobile, Alabama, United States
- Robert H. Lurie Comprehensive Cancer Center, Northwestern University
Chicago, Illinois, United States
- Evanston Hospital
Evanston, Illinois, United States
- Owensboro Medical Health System
Owensboro, Kentucky, United States
- Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
- Erlanger Health Systems
Chattanooga, Tennessee, United States
- Memorial Health Care System
Chattanooga, Tennessee, United States
- Williamson Medical Center
Franklin, Tennessee, United States
- Jackson-Madison County Hospital
Jackson, Tennessee, United States
- Methodist/thompson Oncology Research
Knoxville, Tennessee, United States
- Tennessee Cancer Specialists
Knoxville, Tennessee, United States
- Boston Baskin Cancer Group
Memphis, Tennessee, United States
- St. Thomas Health Services
Nashville, Tennessee, United States
- Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, United States
- Methodist Medical Center of Oak Ridge
Oak Ridge, Tennessee, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 1998
- Primary completion
- 31 Jul 2003
- Completion
- 31 Jul 2003
- Last update posted
- 14 Aug 2012
- Registered enrollment
- 46
- Registry id
- NCT00006104
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.